3/23
08:42 am
cldx
Celldex Therapeutics (CLDX) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $44.00 price target on the stock.
Low
Report
Celldex Therapeutics (CLDX) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $44.00 price target on the stock.
3/23
08:42 am
cldx
Celldex Therapeutics (CLDX) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $44.00 price target on the stock.
Low
Report
Celldex Therapeutics (CLDX) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $44.00 price target on the stock.
3/23
05:44 am
cldx
Celldex upgraded to Outperform from Peer Perform at Wolfe Research
Low
Report
Celldex upgraded to Outperform from Peer Perform at Wolfe Research
3/23
05:44 am
cldx
Celldex upgraded to Outperform from Peer Perform at Wolfe Research
Low
Report
Celldex upgraded to Outperform from Peer Perform at Wolfe Research
3/2
12:10 pm
cldx
Rating for CLDX
Low
Report
Rating for CLDX
3/2
12:10 pm
cldx
Rating for CLDX
Low
Report
Rating for CLDX
3/2
12:10 pm
cldx
Rating for CLDX
Low
Report
Rating for CLDX
2/26
09:26 am
cldx
Celldex Therapeutics (CLDX) had its "buy" rating reaffirmed by Stifel Nicolaus. They now have a $68.00 price target on the stock, up from $58.00.
Medium
Report
Celldex Therapeutics (CLDX) had its "buy" rating reaffirmed by Stifel Nicolaus. They now have a $68.00 price target on the stock, up from $58.00.
2/26
09:26 am
cldx
Celldex Therapeutics (CLDX) had its "buy" rating reaffirmed by Stifel Nicolaus. They now have a $68.00 price target on the stock, up from $58.00.
Medium
Report
Celldex Therapeutics (CLDX) had its "buy" rating reaffirmed by Stifel Nicolaus. They now have a $68.00 price target on the stock, up from $58.00.
2/26
09:18 am
cldx
Rating for CLDX
Medium
Report
Rating for CLDX